APPLICATION
NDA213224
TYPE
NDA
ORIGINAL APPROVAL
2024-09-27
LATEST ACTION
2024-09-27
ROUTE
SUBCUTANEOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
BYNFEZIA PEN · ReferencePrescription
OCTREOTIDE ACETATE EQ 7MG BASE/2.8ML (EQ 2.5MG BASE/ML) · SOLUTION · SUBCUTANEOUS
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.